Protara Therapeutics (TARA) Stock Price, Quote, News & History

Comments

Protara Therapeutics Inc (TARA) Stock Price, Quote, News & History

TARANASDAQ

Trade with Public

$5.90

0.081.37%

Last update: Mar 6, 3:02 PM

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$5.86

Close

-

Volume / Avg.

899.69K / 1.18M

Day Range

$5.65 - $5.96

52 Wk Range

2.77 - 7.82

Market Cap

$316.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

6.28%

Days to Cover

6.15

Recent Protara Therapeutics Inc News

Ultra Clean Posts Downbeat Earnings, Joins Paymentus, Whirlpool And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Protara's Experimental Bladder Cancer Drug Shows Encouraging Results

Protara Therapeutics (TARA) shares down after release of interim results for TARA-002 treatment of Non-Muscle Invasive Bladder Cancer.

Vandana Singh

Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-48.72M

Investing Cash Flow (TTM)

-90.08M

Financing Cash Flow (TTM)

99.60M

Free Cash Flow (TTM)

-48.79M

Capital Expenditure (TTM)

-70.00K

Net Change in Cash (TTM)

-39.21M

Analyst Trends and Forecast

1

Nov 25

1

Dec 25

1

Jan

1

Feb

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$211.80M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.36

Earnings Yield % (TTM)

-23.86%

Earnings Yield % (FWD)

-23.52%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.47

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$12.55M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.86

Close

-

Volume / Avg.

899.69K / 1.18M

Day Range

$5.65 - $5.96

52 Wk Range

2.77 - 7.82

Market Cap

$316.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

6.28%

Days to Cover

6.15

About

Sector

Health Care

Industry

Biotechnology

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. It...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Protara Therapeutics (TARA) stock?

A

You can purchase shares of Protara Therapeutics (NASDAQ:TARA) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Protara Therapeutics (TARA) competitors?

A

Other companies in Protara Therapeutics’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Atrium Therapeutics Inc (NASDAQ:RNA), Immuneering Corp (NASDAQ:IMRX), AC Immune SA (NASDAQ:ACIU) and Enlivex Ltd (NASDAQ:ENLV).

Q

What is the forecast, or price target, for Protara Therapeutics (TARA) stock?

A

Protara Therapeutics has a consensus price target of $22.00.

Q

What is the current price for Protara Therapeutics (TARA)?

A

The stock price for Protara Therapeutics (NASDAQ: TARA) is $5.9 last updated March 6, 2026 at 3:02 PM EST.

Q

Does Protara Therapeutics (TARA) pay a dividend?

A

There are no upcoming dividends for Protara Therapeutics.

Q

When is Protara Therapeutics (NASDAQ:TARA) reporting earnings?

A

Protara Therapeutics does not have any upcoming earnings scheduled.

Q

Is Protara Therapeutics (TARA) going to split?

A

There is no upcoming split for Protara Therapeutics.

Q

What sector and industry does Protara Therapeutics (TARA) operate in?

A

Protara Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Atrium Therapeutics Inc

Fennec Pharmaceuticals Inc

NASDAQ:FENC

$7.71

-2.77%

Abeona Therapeutics Inc

NASDAQ:ABEO

$4.91

0.82%

Key Statistics

Open

$5.86

Close

-

Volume / Avg.

899.69K / 1.18M

Day Range

$5.65 - $5.96

52 Wk Range

2.77 - 7.82

Market Cap

$316.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

6.28%

Days to Cover

6.15

Recent Protara Therapeutics Inc News

Ultra Clean Posts Downbeat Earnings, Joins Paymentus, Whirlpool And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Protara's Experimental Bladder Cancer Drug Shows Encouraging Results

Protara Therapeutics (TARA) shares down after release of interim results for TARA-002 treatment of Non-Muscle Invasive Bladder Cancer.

Vandana Singh

Why Keysight Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-48.72M

Investing Cash Flow (TTM)

-90.08M

Financing Cash Flow (TTM)

99.60M

Free Cash Flow (TTM)

-48.79M

Capital Expenditure (TTM)

-70.00K

Net Change in Cash (TTM)

-39.21M

Analyst Trends and Forecast

1

Nov 25

1

Dec 25

1

Jan

1

Feb

1

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$211.80M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

2.36

Earnings Yield % (TTM)

-23.86%

Earnings Yield % (FWD)

-23.52%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.47

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$12.55M

Debt to Equity

0.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$5.86

Close

-

Volume / Avg.

899.69K / 1.18M

Day Range

$5.65 - $5.96

52 Wk Range

2.77 - 7.82

Market Cap

$316.16M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

6.28%

Days to Cover

6.15

About

Sector

Health Care

Industry

Biotechnology

Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops and delivers breakthrough therapies to people who have limited treatment options. It...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry